AYTU

MKT CAP:$23M

Aytu BioScience Inc

Market Cap

$23M

Healthcare·Drug Manufacturers - Specialty & Generic·🇺🇸 United States·NASDAQ

Healthcare·Drug·🇺🇸·NASDAQ

Stock Price

$2.25-$0.52 (-18.77%)

Jun 5, 2026

52W High $2.9052W Low $1.71

Company Details

Aytu BioPharma, Inc., a pharmaceutical company, focuses on commercializing novel therapeutics in the United States and internationally. The company offers prescription products for the treatment of attention deficit hyperactivity disorder (...

CEO

—

IPO Date

Feb 1, 2017

Website

aytubio.com

Key Metrics TTM

Revenue

$57M

-18.2% YoY

Net Income

-$34M

EPS (Diluted)

Free Cash Flow

$2M

Revenue / Share

$5.38

Gross Margin

62.5%

Operating Margin

-26.8%

Net Margin

-60.2%

FCF Margin

2.9%

P/S

0.4x

P/E

Earnings Reports

Q3 2026

May 13, 2026

$12M-32.7%

Q2 2026

Feb 3, 2026

$15M-6.5%

Q1 2026

Nov 13, 2025

$14M-16.2%

FY 2025

Sep 23, 2025

$66M+1.8%

Q4 2025

Sep 23, 2025

$15M-15.8%

Revenue & Profitability

Valuation

Operating Cash Flow

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Shares Outstanding

Revenue Per Employee

Revenue / Employee